BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26492349)

  • 1. Iodine seed- versus wire-guided localization in breast-conserving surgery for non-palpable ductal carcinoma in situ.
    Luiten JD; Beek MA; Voogd AC; Gobardhan PD; Luiten EJ
    Br J Surg; 2015 Dec; 102(13):1665-9. PubMed ID: 26492349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast conserving surgery for extensive DCIS using multiple radioactive seeds.
    Janssen NNY; van la Parra RFD; Loo CE; Groen EJ; van den Berg MJ; Oldenburg HSA; Nijkamp J; Vrancken Peeters MTFD
    Eur J Surg Oncol; 2018 Jan; 44(1):67-73. PubMed ID: 29239733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcomes after radioactive 125I seed versus hookwire localization of non-palpable breast cancer: a multicentre randomized clinical trial.
    Taylor DB; Bourke AG; Westcott EJ; Marinovich ML; Chong CYL; Liang R; Hughes RL; Elder E; Saunders CM
    Br J Surg; 2021 Jan; 108(1):40-48. PubMed ID: 33640932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide registry study on trends in localization techniques and reoperation rates in non-palpable ductal carcinoma in situ and invasive breast cancer.
    Schermers B; van Riet YE; Schipper RJ; Vrancken Peeters MJ; Voogd AC; Nieuwenhuijzen GAP; Ten Haken B; Ruers TJM
    Br J Surg; 2021 Dec; 109(1):53-60. PubMed ID: 34642736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins.
    Agahozo MC; Berghuis SAM; van den Broek E; Koppert LB; Obdeijn IM; van Deurzen CHM
    Ann Surg Oncol; 2020 Dec; 27(13):5296-5302. PubMed ID: 32578065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonography- and/or mammography-guided breast conserving surgery for ductal carcinoma in situ of the breast: experience with 87 lesions.
    Hayashi N; Tsunoda H; Abe E; Kikuchi M; Enokido K; Tsugawa K; Suzuki K; Nakamura S
    Breast Cancer; 2012 Apr; 19(2):131-7. PubMed ID: 20725871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we abandon wire-guided localization for nonpalpable breast cancer? A plea for wire-guided localization.
    de Roos MA; Welvaart WN; Ong KH
    Scand J Surg; 2013; 102(2):106-9. PubMed ID: 23820686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative ultrasound versus mammographic needle localization for ductal carcinoma in situ.
    James TA; Harlow S; Sheehey-Jones J; Hart M; Gaspari C; Stanley M; Krag D; Ashikaga T; McCahill LE
    Ann Surg Oncol; 2009 May; 16(5):1164-9. PubMed ID: 19267159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ.
    Kropcho LC; Steen ST; Chung AP; Sim MS; Kirsch DL; Giuliano AE
    Breast J; 2012; 18(2):151-6. PubMed ID: 22211816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial.
    Langhans L; Tvedskov TF; Klausen TL; Jensen MB; Talman ML; Vejborg I; Benian C; Roslind A; Hermansen J; Oturai PS; Bentzon N; Kroman N
    Ann Surg; 2017 Jul; 266(1):29-35. PubMed ID: 28257326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomies.
    Law W; Cao X; Wright FC; Slodkowska E; Look Hong N; Curpen B
    Breast J; 2021 Feb; 27(2):134-140. PubMed ID: 33270329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.
    Postma EL; Verkooijen HM; van Esser S; Hobbelink MG; van der Schelling GP; Koelemij R; Witkamp AJ; Contant C; van Diest PJ; Willems SM; Borel Rinkes IH; van den Bosch MA; Mali WP; van Hillegersberg R;
    Breast Cancer Res Treat; 2012 Nov; 136(2):469-78. PubMed ID: 23053639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive seed localization in breast cancer treatment.
    Janssen NN; Nijkamp J; Alderliesten T; Loo CE; Rutgers EJ; Sonke JJ; Vrancken Peeters MT
    Br J Surg; 2016 Jan; 103(1):70-80. PubMed ID: 26503897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
    Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
    J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas.
    Lovrics PJ; Goldsmith CH; Hodgson N; McCready D; Gohla G; Boylan C; Cornacchi S; Reedijk M
    Ann Surg Oncol; 2011 Nov; 18(12):3407-14. PubMed ID: 21533657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of positive resection margins in patients with non-palpable breast cancer.
    Barentsz MW; Postma EL; van Dalen T; van den Bosch MA; Miao H; Gobardhan PD; van den Hout LE; Pijnappel RM; Witkamp AJ; van Diest PJ; van Hillegersberg R; Verkooijen HM
    Eur J Surg Oncol; 2015 Jan; 41(1):106-12. PubMed ID: 25228054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.